What is the current stock price of ProShares - Ultra Nasdaq Biotechnology (BIB)?

As of the latest market data, ProShares - Ultra Nasdaq Biotechnology (BIB) is trading at $81.57. The stock has seen a loss of -3.32% today.

Does ProShares - Ultra Nasdaq Biotechnology (BIB) pay a dividend?

Based on current data, ProShares - Ultra Nasdaq Biotechnology does not have a confirmed active dividend policy.

What is the market cap of ProShares - Ultra Nasdaq Biotechnology?

The current market capitalization of ProShares - Ultra Nasdaq Biotechnology (BIB) is approximately unavailable.

BIB

ProShares - Ultra Nasdaq Biotechnology·Financial Services

81.57

3.317%(−2.80)

Market Closed

98.17

20.356%(+16.60)

After Hours

Last Updated: — ET

52W L: $39.4752W H: $90.91

BIB NEWS

defenseworld.net

Mar 20

ProShares Ultra Nasdaq Biotechnology (NASDAQ:BIB) Stock Price Cross Below 50 Day Moving Average – What’s Next?

ProShares Ultra Nasdaq Biotechnology (NASDAQ: BIB - Get Free Report)'s stock price crossed below its 50-day moving average during trading on Thursday. The stock has a 50-day moving average of $84.02 and traded as low as $75.57. ProShares Ultra Nasdaq Biotechnology shares last traded at $77.7580, with a volume of 9,500 shares changing hands. ProShares

Company Profile

ProShares Ultra Nasdaq Biotechnology seeks daily investment results, before fees and expenses, that correspond to two times (2x) the daily performance of the Nasdaq Biotechnology Index.

Sector

Financial Services

Industry

Asset Management

IPO Date

2010-04-09

Beta

1.42